BCK Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History
Bought
Maintained
Sold
BCK Capital Management's GRNAW Position: Q3 2023 in Review
BCK Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 13,926 shares — an estimated $185 sold.
BCK Capital Management first reported a position in GRNAW in Q1 2023 and held it in 2 quarters. The position peaked at $712 in Q1 2023. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.
- BCK Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
- BCK Capital Management sold 13,926 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $185.
- BCK Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2023 and held it in 2 quarters.
- BCK Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $712 in Q1 2023.
- 1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.
Based on BCK Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.